Taiwan FDA registration 8323fee766c649e9ec640a40e2f0aa3d
INNO-LIA HCV Score
TW: 因諾-立亞人類C型肝炎病毒在線免疫分析試劑組
Taiwan·Risk Class 3·MD·FUJIREBIO EUROPE N.V.·Registered Jan 09, 2020 – Jan 09, 2025CancelledRegistration details
- Analysis ID
- 8323fee766c649e9ec640a40e2f0aa3d
- License Form
- Ministry of Health Medical Device Import No. 033129
- Customs Code
- DHA05603312901
Company information
- Manufacturer
- FUJIREBIO EUROPE N.V.
- Manufacturer Country
- Belgium
- Authorized Representative
- Taiwan Fu Pharmaceutical Co., Ltd
Product details
- Product Type (Level 1)
- B Hematology and pathology devices
- Product Type (Level 2)
- B4020 Analyze specific reagents
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Jan 09, 2020
- Expiry Date
- Jan 09, 2025
- Cancellation Date
- Oct 28, 2022
Cancellation information
- Status
- Logged out
- Reason
- 公司歇業
About this record
Access comprehensive regulatory information for INNO-LIA HCV Score in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 8323fee766c649e9ec640a40e2f0aa3d and manufactured by FUJIREBIO EUROPE N.V.. The authorized representative in Taiwan is Taiwan Fu Pharmaceutical Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices